Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinnan Li

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
European Journal of Medicinal Chemistry|June 9, 2020
Corrigendum to "Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors" [Eur. J. Med. Chem. 197 (2020) 112308]Wen Shuai, Xinnan Li, Wenlong Li, et al.
Brain Research Bulletin|April 19, 2023
Antidepressant effect of 4-Butyl-alpha-agarofuran via HPA axis and serotonin systemHongyue Wang, Jinping Hu, Jiahuan Hu, et al.
Frontiers in Medicine|July 17, 2023
Deep learning system for distinguishing optic neuritis from non-arteritic anterior ischemic optic neuropathy at acute phase based on fundus photographsKaiqun Liu, Shaopeng Liu, Xiao Tan, et al.
European Journal of Medicinal Chemistry|October 18, 2022
Discovery of novel hybrids containing clioquinol-1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's diseaseXinnan Li, Tiantian Li, Pengfei Zhang, et al.
Acta Pharmaceutica Sinica. B|May 4, 2023
Structural diversification of bioactive bibenzyls through modular co-culture leading to the discovery of a novel neuroprotective agentYuyu Liu, Xinnan Li, Songyang Sui, et al.
Multiple Sclerosis and Related Disorders|August 10, 2023
Subclinical damage to the contralateral eye in unilateral optic neuritis: A longitudinal studyYurong Zhang, Yao Qiu, Leyan Chen, et al.
Journal of Thoracic Disease|November 17, 2022
The impact of tubeless anesthesia versus intubated anesthesia on cerebral oxygen saturation and postoperative cognitive function in patients undergoing video-assisted thoracoscopic surgery: a randomized trialYu Huang, Yun Bo, Yujin Li, et al.
Journal of Medicinal Chemistry|June 28, 2021
Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK)Shaowen Xie, Yuan Sun, Yulin Liu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 5, 2025
Erratum to "A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44<sup>+</sup> CD24- enriched breast cancer stem-like cells" [Drug Resist. Updates 66 (2023) 100903]Caigang Liu, Yixiao Zhang, Jiujiao Gao, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 4, 2022
A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44<sup>+</sup>CD24<sup>-</sup> enriched breast cancer stem-like cellsCaigang Liu, Yixiao Zhang, Jiujiao Gao, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Medicinal Chemistry|June 9, 2020
Corrigendum to "Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors" [Eur. J. Med. Chem. 197 (2020) 112308]Wen Shuai, Xinnan Li, Wenlong Li, et al.
Brain Research Bulletin|April 19, 2023
Antidepressant effect of 4-Butyl-alpha-agarofuran via HPA axis and serotonin systemHongyue Wang, Jinping Hu, Jiahuan Hu, et al.
Frontiers in Medicine|July 17, 2023
Deep learning system for distinguishing optic neuritis from non-arteritic anterior ischemic optic neuropathy at acute phase based on fundus photographsKaiqun Liu, Shaopeng Liu, Xiao Tan, et al.
European Journal of Medicinal Chemistry|October 18, 2022
Discovery of novel hybrids containing clioquinol-1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's diseaseXinnan Li, Tiantian Li, Pengfei Zhang, et al.
Acta Pharmaceutica Sinica. B|May 4, 2023
Structural diversification of bioactive bibenzyls through modular co-culture leading to the discovery of a novel neuroprotective agentYuyu Liu, Xinnan Li, Songyang Sui, et al.
Multiple Sclerosis and Related Disorders|August 10, 2023
Subclinical damage to the contralateral eye in unilateral optic neuritis: A longitudinal studyYurong Zhang, Yao Qiu, Leyan Chen, et al.
Journal of Thoracic Disease|November 17, 2022
The impact of tubeless anesthesia versus intubated anesthesia on cerebral oxygen saturation and postoperative cognitive function in patients undergoing video-assisted thoracoscopic surgery: a randomized trialYu Huang, Yun Bo, Yujin Li, et al.
Journal of Medicinal Chemistry|June 28, 2021
Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK)Shaowen Xie, Yuan Sun, Yulin Liu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 5, 2025
Erratum to "A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44<sup>+</sup> CD24- enriched breast cancer stem-like cells" [Drug Resist. Updates 66 (2023) 100903]Caigang Liu, Yixiao Zhang, Jiujiao Gao, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 4, 2022
A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44<sup>+</sup>CD24<sup>-</sup> enriched breast cancer stem-like cellsCaigang Liu, Yixiao Zhang, Jiujiao Gao, et al.
Pageof 8